| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Wednesday’s Close |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $105.71 | $113.53B | N/A |
Top Research Reports for Alphabet, Eli Lilly & CVS Health
http://www.zacks.com/research-daily/413862/top-research-reports-for-alphabet-eli-lilly-cvs-health?cid=CS-ZC-FT-413862
May 14, 2019 - Top Research Reports for Alphabet, Eli Lilly & CVS Health
0
Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer
http://www.zacks.com/stock/news/413860/lillys-cyramza-gets-fda-nod-for-second-line-liver-cancer?cid=CS-ZC-FT-413860
May 14, 2019 - Lilly's (LLY) Cyramza gets FDA approval to treat AFP-high hepatocellular carcinoma (HCC), a common form of liver cancer. FDA removes boxed warning from label.
0
Why Are Investors Passing on Teva Pharmaceutical Industries?
https://www.fool.com/investing/2019/05/05/why-are-investors-passing-on-teva-pharmaceutical-i.aspx?source=iedfolrf0000001
May 05, 2019 - Teva's turnaround won't kick into high gear anytime soon.
0
Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down
http://www.zacks.com/stock/news/408333/teva-teva-q1-earnings-beat-copaxone-drags-sales-down?cid=CS-ZC-FT-408333
May 03, 2019 - Teva Pharmaceutical (TEVA) beats estimates for earnings but misses the same for sales. Blockbuster drug Copaxone sales continue to erode amid generic competition.
0
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod
http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311
May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
0
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
http://www.zacks.com/stock/news/407647/united-therapeutics-uthr-down-despite-q1-earnings-beat?cid=CS-ZC-FT-407647
May 02, 2019 - United Therapeutics (UTHR) beats estimates on both fronts in the first quarter. However, earnings and revenues decline year over year.
0
Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice
http://www.zacks.com/stock/news/406364/are-you-looking-for-a-high-growth-dividend-stock-eli-lilly-lly-could-be-a-great-choice?cid=CS-ZC-FT-406364
May 01, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.
0
Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2019/04/30/eli-lilly-and-company-lly-q1-2019-earnings-call-tr.aspx?source=iedfolrf0000001
Apr 30, 2019 - LLY earnings call for the period ending March 31, 2019.
0
Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4258185-eli-lilly-companys-lly-ceo-dave-ricks-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare
Apr 30, 2019 - Eli Lilly and Company (NYSE:LLY) Q1 2019 Results Earnings Conference Call April 30, 2019, 9:00 AM ET Company Participants Kevin Hern - Vice President, Investor Relations Dave Ricks - Chairman and CEO
0
3 Tech Stocks for Growth Investors to Buy Right Now
http://www.zacks.com/stock/news/406067/3-tech-stocks-for-growth-investors-to-buy-right-now?cid=CS-ZC-FT-406067
Apr 30, 2019 - Let's check out three tech stocks that came through our screen today that growth investors might want to consider at the moment...
0